Peak Asset Management, LLC Sarepta Therapeutics, Inc. Transaction History

Peak Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	BUY	$100.86 - $132.13 $173,479 - $227,263	1,720 New	1,720 $222,000
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $102,595 - $239,908	-1,420 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $178,295 - $253,810	1,420 New	1,420 $242,000
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $262,725 - $485,052	-2,825 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$82.38 - $131.64 $232,723 - $371,882	2,825 New	2,825 $276,000

536

87.4M

1.55M

1.35M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $8.73B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Peak Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Peak Asset Management, LLC with notifications on news.